Ischemia-Reperfusion Lung Injury Is Attenuated in MyD88-Deficient Mice

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Altemeier, William A ^a   Liles, W Conrad ^a,b   Villagra Garcia, Ana ^b   Matute Bello, Gustavo ^a   Glenny, Robb W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; LUNG INJURY; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PHENOTYPE; PNEUMONIA; PROTEIN DEPLETION; PROTEIN EXPRESSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ACUTE LUNG INJURY; ANIMALS; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; HEK293 CELLS; HUMANS; LIGANDS; LUNG; MICE; MICE, KNOCKOUT; MYELOID CELLS; MYELOID DIFFERENTIATION FACTOR 88; PERMEABILITY; PEROXIDASE; PULMONARY ALVEOLI; REPERFUSION INJURY; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 84885394079     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077123     Document Type: Article

References (46)

1. de Perrot M, Liu M, Waddell TK, Keshavjee S, (2003) Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167: 490-511. doi:10.1164/rccm.200207-670SO. PubMed: 12588712.
2. King RC, Binns OA, Rodriguez F, Kanithanon RC, Daniel TM, et al. (2000) Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 69: 1681-1685. doi:10.1016/S0003-4975(00)01425-9. PubMed: 10892906.
3. Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, et al. (2002) Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 73: 1041-8 10.1016/S0003-4975(01)03606-2. PubMed: 11996238.
4. Eppinger MJ, Jones ML, Deeb GM, Bolling SF, Ward PA, (1995) Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res 58: 713-718. doi:10.1006/jsre.1995.1112. PubMed: 7791351.
5. Belperio JA, Keane MP, Burdick MD, Gomperts BN, Xue YY, et al. (2005) CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J Immunol 175: 6931-6939. PubMed: 16272353.
6. de Perrot M, Sekine Y, Fischer S, Waddell TK, McRae K, et al. (2002) Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165: 211-215. doi:10.1164/ajrccm.165.2.2011151. PubMed: 11790657.
7. Hoffman SA, Wang L, Shah CV, Ahya VN, Pochettino A, et al. (2009) Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 9: 389-396. doi:10.1111/j.1600-6143.2008.02497.x. PubMed: 19120076.
8. Shah RJ, Diamond JM, Lederer DJ, Arcasoy SM, Cantu EM, et al. (2012) Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation. Transl Res 160: 435-442. doi:10.1016/j.trsl.2012.08.003. PubMed: 22989614.
9. Roebuck KA, (1999) Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 19: 429-438. doi:10.1089/107999099313866. PubMed: 10386854.
10. Ishii M, Suzuki Y, Takeshita K, Miyao N, Kudo H, et al. (2004) Inhibition of c-Jun NH2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol 172: 2569-2577. PubMed: 14764730.
11. Ross SD, Kron IL, Gangemi JJ, Shockey KS, Stoler M, et al. (2000) Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-kappaB. Am J Physiol Lung Cell Mol Physiol 279: L528-L536. PubMed: 10956628.
12. Haddad JJ, (2003) Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for hypoxia-inducible factor-1alpha. Crit Care 7: 47-54. doi:10.1186/cc2243. PubMed: 12617740.
13. Henderson WR, Chi EY, Teo JL, Nguyen C, Kahn M, (2002) A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J Immunol 169: 5294-5299. PubMed: 12391249.
14. Naidu BV, Fraga C, Salzman AL, Szabo C, Verrier ED, et al. (2003) Critical role of reactive nitrogen species in lung ischemia-reperfusion injury. J Heart Lung Transplant 22: 784-793. doi:10.1016/S1053-2498(02)00556-9. PubMed: 12873547.
15. Zhang X, Shan P, Jiang D, Noble PW, Abraham NG, et al. (2004) Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 279: 10677-10684. doi:10.1074/jbc.M312941200. PubMed: 14688267.
16. Janssens S, Beyaert R, (2002) A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci 27: 474-482. doi:10.1016/S0968-0004(02)02145-X. PubMed: 12217523.
17. Takeuchi O, Akira S, (2002) MyD88 as a bottle neck in Toll/IL-1 signaling. Curr Top Microbiol Immunol 270: 155-167. doi:10.1007/978-3-642-59430-4_10. PubMed: 12467250.
18. Land WG, (2005) The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 79: 505-514. doi:10.1097/01.TP.0000153160.82975.86. PubMed: 15753838.
19. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJD, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903. doi:10.1172/JCI22832. PubMed: 16167081.
20. Wu HS, Zhang JX, Wang L, Tian Y, Wang H, et al. (2004) Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. HBPD Int 3: 250-253. PubMed: 15138120.
21. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, et al. (2005) Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 175: 7661-7668. PubMed: 16301676.
22. Oyama JI, Blais C, Liu X, Pu M, Kobzik L, et al. (2004) Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109: 784-789. doi:10.1161/01.CIR.0000112575.66565.84. PubMed: 14970116.
23. Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, et al. (2004) Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128: 170-179. doi:10.1016/j.jtcvs.2003.11.036. PubMed: 15282452.
24. Stapel H, Kim SC, Osterkamp S, Knuefermann P, Hoeft A, et al. (2006) Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: Role of matrix metalloproteinases. Eur J Heart Fail 8: 665-672. doi:10.1016/j.ejheart.2006.03.005. PubMed: 16829192.
25. Shimamoto A, Pohlman TH, Shomura S, Tarukawa T, Takao M, et al. (2006) Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg 82: 2017-2023. doi:10.1016/j.athoracsur.2006.06.079. PubMed: 17126102.
26. Zanotti G, Casiraghi M, Abano JB, Tatreau JR, Sevala M, et al. (2009) Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol 297: L52-L63. doi:10.1152/ajplung.90406.2008. PubMed: 19376887.
27. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, et al. (2007) TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. J Immunol 178: 6252-6258. PubMed: 17475853.
28. Farrar CA, Keogh B, McCormack W, O'Shaughnessy A, Parker A, et al. (2012) Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J 26: 799-807. doi:10.1096/fj.11-195396. PubMed: 22042224.
29. Arslan F, Smeets MB, O'Neill LAJ, Keogh B, McGuirk P, et al. (2010) Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 121: 80-90. doi:10.1161/CIRCULATIONAHA.109.880187. PubMed: 20026776.
30. Lu C, Liu L, Chen Y, Ha T, Kelley J, et al. (2011) TLR2 ligand induces protection against cerebral ischemia/reperfusion injury via activation of phosphoinositide 3-kinase/Akt signaling. J Immunol 187: 1458-1466. doi:10.4049/jimmunol.1003428. PubMed: 21709150.
31. Huang H, Evankovich J, Yan W, Nace G, Zhang L, et al. (2011) Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 54: 999-1008. doi:10.1002/hep.24501. PubMed: 21721026.
32. Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, et al. (2010) Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51: 621-632. doi:10.1002/hep.23365. PubMed: 19902481.
33. Mathur S, Walley KR, Boyd JH, (2011) The Toll-like receptor 9 ligand CPG-C attenuates acute inflammatory cardiac dysfunction. Shock 36: 478-483. doi:10.1097/SHK.0b013e31822d6442. PubMed: 21937956.
34. Kim KH, Burkhart K, Chen P, Frevert CW, Randolph-Habecker J, et al. (2005) Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am J Respir Cell Mol Biol 33: 271-279. doi:10.1165/rcmb.2005-0111OC. PubMed: 15947421.
35. Matute-Bello G, Lee JS, Frevert CW, Liles WC, Sutlief S, et al. (2004) Optimal timing to repopulation of resident alveolar macrophages with donor cells following total body irradiation and bone marrow transplantation in mice. J Immunol Methods 292: 25-34. doi:10.1016/j.jim.2004.05.010. PubMed: 15350509.
36. Miyake K, (2007) Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 19: 3-10. doi:10.1016/j.smim.2006.12.002. PubMed: 17275324.
37. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, et al. (2006) Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26: 430-437. doi:10.1097/01.shk.0000228797.41044.08. PubMed: 17047512.
38. Tsan MF, Gao B, (2004) Endogenous ligands of Toll-like receptors. J Leukoc Biol 76: 514-519. doi:10.1189/jlb.0304127. PubMed: 15178705.
39. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, et al. (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2: 253-258. doi:10.1016/S1097-2765(00)80136-7. PubMed: 9734363.
40. Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, et al. (2006) Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114: I270-I274. doi:10.1161/CIRCULATIONAHA.105.000901. PubMed: 16820585.
41. Hua F, Ha T, Ma J, Li Y, Kelley J, et al. (2007) Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J Immunol 178: 7317-7324. PubMed: 17513782.
42. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, et al. (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201: 1135-1143. doi:10.1084/jem.20042614. PubMed: 15795240.
43. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859. doi:10.1172/JCI31008. PubMed: 17853945.
44. Jiang D, Liang J, Fan J, Yu S, Chen S, et al. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11: 1173-1179. doi:10.1038/nm1315. PubMed: 16244651.
45. Krieg AM, Vollmer J, (2007) Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 220: 251-269. doi:10.1111/j.1600-065X.2007.00572.x.
46. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, et al. (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133: 235-249. doi:10.1016/j.cell.2008.02.043. PubMed: 18423196.